2010
DOI: 10.1016/j.biomaterials.2009.11.086
|View full text |Cite
|
Sign up to set email alerts
|

Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone

Abstract: Targeted gene therapy can potentially minimize undesirable off-target toxicity due to specific delivery. Neuron-specific gene delivery in the central nervous system is challenging because neurons are non-dividing and also outnumbered by glial cells. One approach is to transfect dividing neural stem and progenitor cells (NSCs and NPCs, respectively). In this work, we demonstrate cell-specific gene delivery to NPCs in the brains of adult mice using a peptide-modified polymeric vector. Tet1, a 12-amino acid pepti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
49
2

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 69 publications
(52 citation statements)
references
References 35 publications
1
49
2
Order By: Relevance
“…17,18 In addition, gene expression in the lateral ventricle was reported after administration of Tet1-PEG-b-polyethylenimine containing plasmid DNA. 6 This indicated that the PMs might release their cargos in the distal axon compartment, which could then penetrate separately into the cell body compartment of the neuron. Thus, Tet1-PMs could target the neurofilament of the CN; however, whether they effectively release their cargo into the cytoplasm needs further investigation.…”
Section: Neurofilament Targeting Of the Tet1-pms After Intracochlear mentioning
confidence: 99%
See 1 more Smart Citation
“…17,18 In addition, gene expression in the lateral ventricle was reported after administration of Tet1-PEG-b-polyethylenimine containing plasmid DNA. 6 This indicated that the PMs might release their cargos in the distal axon compartment, which could then penetrate separately into the cell body compartment of the neuron. Thus, Tet1-PMs could target the neurofilament of the CN; however, whether they effectively release their cargo into the cytoplasm needs further investigation.…”
Section: Neurofilament Targeting Of the Tet1-pms After Intracochlear mentioning
confidence: 99%
“…Modification of nanoparticles with the Tet1 peptide has resulted in improved targeted gene delivery to neurons both in vitro and in vivo. 6,7 We hypothesized that SGCs or CN targeted drug delivery could be achieved by using PEG-b-PCL PMs functionalized with the Tet1 peptide. In our previous study, unlabelled PMs that were delivered onto the round window membrane (RWM) did not appear in SGCs and spiral ganglion satellite cells.…”
Section: Introductionmentioning
confidence: 99%
“…17 The phage display test revealed that a 12-amino acid peptide, Tet-1, possesses a high affinity for GT1B receptor. 18,19 When plasmid DNA encoding luciferase was condensed with Tet1-polyethylene glycol (PEG)-polyethyleneimine and delivered via intracerebroventricular injection to mice, the GT1B-positive stain of transfected nerve cells was observed after delivery of Tet1-mediated vector (58%) as compared to untargeted vector (13%). 18 In most studies, two ligands modified the nanoparticles were used for cancer therapy; these ligands identified the receptors on the tumor cells so as to achieve a sequential targeting action.…”
Section: Introductionmentioning
confidence: 99%
“…18,19 When plasmid DNA encoding luciferase was condensed with Tet1-polyethylene glycol (PEG)-polyethyleneimine and delivered via intracerebroventricular injection to mice, the GT1B-positive stain of transfected nerve cells was observed after delivery of Tet1-mediated vector (58%) as compared to untargeted vector (13%). 18 In most studies, two ligands modified the nanoparticles were used for cancer therapy; these ligands identified the receptors on the tumor cells so as to achieve a sequential targeting action. Bhattacharyya et al 20 developed a gold nanoparticle functionalized by EGF receptor and folate antibody for the treatment of ovarian cancer in which the cancer cells expressed EGF receptor and folate receptor.…”
Section: Introductionmentioning
confidence: 99%
“…16 Modified transfection reagents, ie, PEI-PEG and Tet1 complexes, demonstrated increased luciferase expression levels in neural progenitor cells compared with unmodified PEI-PEG complexes. 17 In this study, we investigated the use of novel synthesized magnetic nanoparticles for gene delivery in neuronal cells. Magnetic PEI/poly(methyl methacrylate) (PMMA) core-shell (mag-PEI) nanoparticles were prepared using ultrasonicationassisted emulsifier-free emulsion polymerization.…”
Section: Introductionmentioning
confidence: 99%